Ocean Biomedical, Inc.
NASDAQ:OCEA
0.9774 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -0.958 | -62.344 | -1.653 | -0.232 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 56.55 | 0 | 0 |
| Change In Working Capital
| 1.735 | 4.741 | 1.589 | 0.232 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.29 | 0 | 0 | 0 |
| Other Working Capital
| 1.445 | 4.741 | 0 | 0 |
| Other Non Cash Items
| -1.524 | -0.002 | 0 | 0 |
| Operating Cash Flow
| -0.747 | -1.053 | -0.064 | 0 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -2.1 | -107.1 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
| Other Investing Activites
| -2.1 | 0 | 0 | 0 |
| Investing Cash Flow
| -2.1 | -107.1 | 0 | 0 |
| Financing Activities: | ||||
| Debt Repayment
| -2.1 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 1.017 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.2 | 0.096 | 0.064 | 0 |
| Financing Cash Flow
| 2.1 | 1.113 | 0.064 | 0 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 107.1 | 0 | 0 |
| Net Change In Cash
| -0.747 | 0.06 | 0 | 0 |
| Cash At End Of Period
| 0.328 | 0.06 | 0 | 0 |